2809 Results

People

  1. Fong
    Fong
  2. Abu-Rustum
    Abu-Rustum
  3. Chi
    Chi
  4. Reuter
    Reuter
  5. Barakat
    Barakat
  6. DeMatteo
    DeMatteo
  7. Gonen
    Gonen
  8. Klimstra
    Klimstra
  9. Gerald
    Gerald
  10. Hudis
    Hudis

Groups

  1. Department of Medicine (779)
  2. Surgery (721)
  3. GSK Faculty (507)
  4. Sloan Kettering Institute Faculty (471)
  5. Solid Tumor Oncology Division (455)
  6. Survivorship Research (381)
  7. Department of Pathology and Laboratory Medicine (285)
  8. Population Sciences Research Program (265)
  9. Epidemiology and Biostatistics (253)
  10. Molecular Pharmacology and Chemistry Program Faculty (250)
  1. "2008"
Formats
  1. Journal Article (1794)
  2. Meeting Abstract (728)
  3. Book Section (244)
  4. Conference Paper (25)
  5. Book Whole (18)
Groups
  1. Department of Medicine (779)
  2. Surgery (721)
  3. GSK Faculty (507)
  4. Sloan Kettering Institute Faculty (471)
  5. Solid Tumor Oncology Division (455)
  6. Survivorship Research (381)

More Groups

People
  1. David Klimstra (60)
  2. Yuman Fong (56)
  3. Nadeem Abu-Rustum (55)
  4. Peter Scardino (52)
  5. Robert Soslow (52)
  6. Dennis Chi (51)

More People

Years
  1. 2008 (2809)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (83)
  3. International Journal of Radiation Oncology, Biology, Physics (71)
  4. Modern Pathology (65)
  5. Cancer Research (59)
  6. Gynecologic Oncology (59)

More Publications

Publishers
  1. Elsevier Inc. (340)
  2. American Society of Clinical Oncology (230)
  3. Lippincott Williams & Wilkins (164)
  4. Nature Publishing Group (150)
  5. Springer (143)
  6. Elsevier Science, Inc. (131)

More Publishers

Results (2809)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity and tolerance of XL647 in NSCLC patients with acquired resistance to EGFR-TKIs: Preliminary results of a phase II trial
    Meeting Abstract

    Miller, V. A.; Wakelee, H. A.; Lara, P. N.; Cho, J.; Chowhan, N. M.; Costa, D.; Vrindavanam, N.; Yanagihara, R.; Pennell, N.; Lynch, T. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib
    Meeting Abstract

    Jackman, D. M.; Sequist, L. V.; Cioffredi, L.; Gallegos Ruiz, M.; Janne, P. A.; Giaccone, G.; Miller, V. A.; Johnson, B. E.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies
    Meeting Abstract

    Wilson, W. H.; Czuczman, M. S.; LaCasce, A. S.; Gerecitano, J. F.; Leonard, J. P.; Dunleavy, K.; Krivoshik, A. P.; Xiong, H.; Chiu, Y.; O'Connor, O. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study evaluating two dosing schedules of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J. F.; Portlock, C.; Hamlin, P.; Moskowitz, C.; Noy, A.; Straus, D. J.; Zelenetz, A. D.; Schulman, P.; Dumitrescu, O.; O'Connor, O. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma
    Meeting Abstract

    Chen-Kiang, S.; Di Liberto, M.; Louie, T.; Liang, J.; Jayabalan, D. S.; Ely, S.; Moore, M. A.; Niesvizky, R.; Huang, X.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib
    Meeting Abstract

    Costa, D. B.; Cho, B. C.; Sequist, L. V.; Riely, G. J.; Halmos, B.; Kim, J.; Huberman, M. S.; Pao, W.; Tenen, D. G.; Kobayashi, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prospective comparison of postoperative quality of life (QOL) in patients undergoing lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Park, B. J.; Ishill, N. M.; Flores, R. M.; Gawiak, C. T.; Shen, R.; Rizk, N.; Bains, M. S.; Downey, R. J.; Ostroff, J.; Burkhalter, J.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Reproducibility of computed tomography (CT) measurements of lung cancer
    Meeting Abstract

    James, L. P.; Zhao, B.; Moskowitz, C. S.; Riely, G. J.; Miller, V. A.; Guo, P.; Ginsberg, M. S.; Kris, M. G.; Schwartz, L. H.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Marks, J. L.; Li, A.; Chitale, D. A.; Riedel, E. R.; Hsu, M.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save